Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modified Tian Wang Bu Xin Dan Hydrogel Patch in Postoperative Delirium
NCT04947761Phase 4Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Jul 2021
- Primary completion
- Dec 2022
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative delirium (POD) comparing Modified Cheonwangbosimdan Hydrogel patch with Placebo patch (2 arms). Primary endpoint: Incidence of inpatient post-operative delirium as measured using the 3D-confusion assessment method (3D-CAM). Status: unknown.
02
Drugs
Modified Tian Wang Bu Xin Dan
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT04947761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04947761.